Kratom Research Institute

News · 2026-08-18

Vivazen Launches Safe Shelves Initiative to Help Retailers Identify Legal Products After DEA 7-OH Scheduling

Source: Nutritional Outlook

Why it matters

With DEA's 7-OH scheduling imminent, thousands of small retailers across the country face genuine uncertainty about which products they can legally sell. Vivazen's SafeShelves.org provides a free, publicly accessible compliance resource — a practical response to the enforcement gap left by the DEA action.

The big picture

The DEA's July 1, 2026, notice proposed temporarily classifying 7-OH above 0.050% concentration — and its three related synthetic compounds — as Schedule I drugs. The action targets synthetic, concentrated forms, not the kratom botanical itself. But many retail products blur that line, and small operators lack the scientific expertise to evaluate certificates of analysis. Vivazen, which sells natural botanical kratom products, positioned its Safe Shelves Initiative as an industry-facing compliance tool and a way to accelerate removal of illegal products from store shelves.

Key findings

What they say

"As retailers move quickly to comply with DEA's 7-OH scheduling decision, many are facing questions and confusion about which products they are legally permitted to sell. The Safe Shelves Initiative is designed to reduce the known harms of 7-OH by arming our industry partners with clear resources on how to navigate this transition with confidence," said Mike Valenti, SVP of Sales at Vivazen.

Bottom line

Vivazen's Safe Shelves Initiative gives retailers a free, practical compliance tool to identify which products are legal after the DEA's 7-OH scheduling — filling a real gap in the absence of government guidance targeted at small operators.